Fundación de investigación HM   Report issue

Foundation Phase 2 Phase 3
Founded: Barcelona Spain (2003)

Organization Overview

First Clinical Trial
2013
NCT02928432
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundación de investigación HM